🔗 Permalink

Inventor profile of:

Michael Platten

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Michael Platten

The entities that hold a legal rights for patent applications filed by inventor Platten Michael:

Deutsches Krebsforschungszentrum 11 Heidelberg, Germany
Bayer Pharma Aktiengesellschaft 8 Berlin, Germany
Bayer Aktiengesellschaft 7 Leverkusen, Germany
Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts 2 Heidelberg, Germany
RUPRECHT-KARLS-UNIVERISTAET HEIDELBERG 1 Heidelberg, Germany
Universitat Heidelberg 1 Heidelberg, Germany
RUPRECHT-KARLS-UNIVERSITÄT 1 Heidelberg, Germany
Deutsches Krebsforschungszentrum 1 , Germany
RUPRECHT-KARLS-UNIVERSITAT 1 Heidelberg, Germany
ELECTROPHORETICS LIMITED 1 London, United Kingdom
DEUTSCHLAND KREBSFORSCHUNGSZENTRUM 1 Heidelberg, Germany
DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM 1 Heidelberg, Germany
DEUTSCHES KREBSFORSCHUNGSZENTRUM (DKFZ) 1 Heidelberg, Germany

Recent patent applications by Platten Michael

Michael Platten from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260098036A1

Chemistry; metallurgy

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

#2 | 2025-09-04

US20250277013A1

Chemistry; metallurgy

T CELL RECEPTOR DERIVED BINDING POLYPEPTIDES

#3 | 2025-08-28

US20250270640A1

Chemistry; metallurgy

ANTIGEN REACTIVE T-CELL RECEPTORS

#4 | 2024-09-05

US20240294505A1

Chemistry; metallurgy

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

#5 | 2023-04-20

US20230121195A1

Chemistry; metallurgy

2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer

#6 | 2023-04-13

US20230113037A1

Chemistry; metallurgy

[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES

#7 | 2020-12-03

US20200377562A1

Chemistry; metallurgy

Histone anti-cancer vaccines

#8 | 2020-09-24

US20200299269A1

Chemistry; metallurgy

Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides

#9 | 2020-09-17

US20200289509A1

Human necessities

2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists

#10 | 2020-09-10

US20200283402A1

Chemistry; metallurgy

3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides

#11 | 2020-09-10

US20200283395A1

Chemistry; metallurgy

2-phenylpyrimidine-4-carboxamides as AHR inhibitors

#12 | 2020-07-30

US20200237757A1

Human necessities

3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides

#13 | 2018-08-30

US20180246118A1

Physics

Isotopic methods for measurement of tryptophan and metabolites thereof

#14 | 2018-06-07

US20180155403A1

Chemistry; metallurgy

HISTONE ANTI-CANCER VACCINES

#15 | 2017-09-07

US20170254803A1

Physics

METHOD FOR THE DETECTION OF ANTIGEN PRESENTATION

#16 | 2015-01-22

US20150023991A1

Physics

Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers

#17 | 2014-10-02

US20140294860A1

Chemistry; metallurgy

Means and methods for treating and/or preventing natural AHR ligand-dependent cancer

InventorID:

920741 ⎘